Abstract
Small vessel disease is a common cause of cerebrovascular disease. It is responsible for ischemic and hemorrhagic strokes, cognitive decline, and asymptomatic disease. Millions of Americans are affected by silent strokes and white matter abnormalities. Lacunar stroke is the most common manifestation. Despite its importance, small vessel strokes remain understudied. There is a need for research focused on this prevalent stroke subtype to define optimal interventions to prevent stroke recurrence and cognitive impairment.
Similar content being viewed by others
References and Recommended Reading
Fisher CM: Lacunar strokes and infarcts: a review. Neurology 1982, 32:871–876. This is a thorough review of lacunar infarcts with pathologic characterization, mechanism of disease, and clinical correlations.
Kolominsky-Rabas PL, Weber M, Gefeller O, et al.: Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in inschemic stroke subtypes: a population-based study. Stroke 2001, 32:2735–2740.
Wolfe CDA, Rudd AG, Howard R, et al.: Incidence and case fatality rates of stroke subtypes in a multiethnic population: the South London Stroke Register. J Neurol Neurosurg Psychiatry 2002, 72:211–216.
Bogousslavsky J, Van Melle G, Regli F: The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. For the Lausanne Stroke Registry Group. Stroke 1988, 19:1083–1092.
Saposnik G, Gonzalez L, Lepera S, et al.: Southern Buenos Aires stroke project. Acta Neurol Scand 2001, 104:130–135.
Del Brutto OH, Mosquera A, Sanchez X, et al.: Stroke subtypes among Hispanics living in Guayaquil, Ecuador. Results from the Luis Vernaza Hospital Stroke Registry. Stroke 1993, 24:1833–1836.
Lavados P: The PISCIS project: incidence of stroke in Iquique, Chile: final results of a community based study [abstract]. Presented at the 5th World Congress of Cerebrovascular Disease. Vancouver, CA; June 23–26, 2004.
Corbin DO, Poddar V, Hennis A, et al.: Incidence and case fatality rates of first-ever stroke in a black Caribbean population: the Barbados Register of Strokes. Stroke 2004, 35:1254–1258.
Anderson C: Ethnic disparities in the incidence of ischemic stroke subtypes: findings from the Auckland Regional Community Stroke (ARCOS) Study of 2002–2003 [abstract]. Presented at the 5th World Congress of Cerebrovascular Disease. Vancouver, CA; 2004.
Gan R, Sacco RL, Kargman DE, et al.: Testing the validity of the lacunar hypothesis: the Northern Manhattan Stroke Study experience. Neurology 1997, 48:1204–1211.
Wong KS, Gao S, Chan YL, et al.: Mechanisms of acute cerebral infarction in patients with middle cerebral artery stenosis: a diffussion-weighted imaging and microemboli monotoring study. Ann Neurol 2002, 52:74–81.
Tejada J, Diez-Tejedor E, Hernandez-Echebarria L, Balboa O: Does a relationship exist between carotid stenosis and lacunar infarction? Stroke 2003, 34:1404–1409.
Tegler CH, Shi F, Morgan T: Carotid stenosis in lacunar stroke. Stroke 1992, 23:437–438.
Arboix A, Padilla I, Massons J, et al.: Clinical study of 222 patients with pure motor stroke. J Neurol Neurosurg Psychiatry 2001, 71:239–242.
Babikian V, Ropper AH: Binswanger's disease: a review. Stroke 1987, 18:2–12.
Mantyla R, Aronen HJ, Salonen O, et al.: Magnetic resonance imaging white matter hyperintensities and mechanism of ischemic stroke. Stroke 1999, 30:2053–2058.
Benavente O, Hart RG, Palacio S, et al.: Secondary Prevention of Small Subcortical Strokes (SPS3) pilot trial: final results [abstract]. Stroke 2003, 34:238.
Toni D, Iweins F, von Kummer R, et al.: Identification of lacunar infarcts before thrombolysis in the ECASS I study. Neurology 2000, 54:684–688.
Stapf C, Hofmeister C, Hartmann A, et al.: Predictive value of clinical lacunar syndromes for lacunar infarcts on magnetic resonance brain imaging. Acta Neurol Scand 2000, 101:13–18.
Schoneville W, Tuhrim S, Singer M, Atlas S: Diffusion-weighted MRI in acute lacunar syndromes: a clinical-radiological correlation study. Stroke 1999, 30:2066–2069.
Lai PH, Li JY, Chang CY, et al.: Sensitivity of diffusionweighted magnetic resonance imaging in the diagnosis of acute lacunar infarcts. J Formos Med Assoc 2001, 100:370–376.
Janssens E, Mounier-Vehier F, Hamon M, Leys D: Small subcortical infarcts and primary subcortical haemorrhages may have different risk factors. J Neurol 1995, 242:425–429.
Lammie AG, Brannan F: Nonhypertensive cerebral smallvessel disease. Stroke 1997, 28:2222–2229.
Dozono K, Ishii N, Nishihara Y, Horie A: An autopsy study of the incidence of lacunes in relation to age, hypertension, and arteriosclerosis. Stroke 1991, 22:993–996.
Eguchi K, Kario K, Shimada K: Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts. Stroke 2003, 34:2471–2474.
van Swieten JC, Geyskes GG, Derix MMA, et al.: Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 1991, 30:825–830.
Boiten J, Luijckx GJ, Kessels F, Lodder J: Risk factors for lacunes. Neurology 1996, 47:1109–1110.
Megherbi SE, Milan C, Minier D, et al.: Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke 2003, 34:688–694.
Bamford JM, Sandercock P, Jones L, Warlow CP: The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. Stroke 1987, 18:545–551.
Landi G, Cella E, Boccardi E, Musicco M: Lacunar versus non-lacunar infarcts: pathogenetic and prognostic differences. J Neurol Neurosurg Psychiatry 1992, 55:441–445.
Boiten J, Lodder J: Prognosis for survival, handicap and recurrence of stroke in lacunar and superficial stroke. Cerebrovasc Dis 1993, 3:221–226.
Petty GW, Brown RDJ, Whisnant JP, et al.: Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke 2000, 31:1062–1068.
Mohr JP, Thompson JLP, Lazar RM, et al.: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001, 345:1444–1451.
Brainini M, Seiser A, Czvitkovits B, Pauly E: Stroke subtype is an age-independent predictor of first-year survival. Neuroepidemiology 1992, 11:190–195.
Kuller LH, Longstreth WT Jr., Arnold AM, et al.: White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004, 35:1821–1825.
Miyao S, Takano A, Teramoto J, Takahashi A: Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke 1992, 23:1434–1438.
Arauz A, Murillo L, Cantu C, et al.: Prospective study of single and multiple lacunar infarcts using magnetic resonance imaging: risk factors, recurrence, and outcome in 175 consecutive cases. Stroke 2003, 34:2453–2458.
Snowdon DA, Greiner LH, Mortimer JA: Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997, 277:813–817. An important report providing evidence of the significance of lacunar infarcts as a cause of dementia.
Tatemichi TK, Desmond D, Paik M, et al.: Clinical determinants of dementia related to stroke. Ann Neurol 1993, 33:568–575.
Tatemichi TK, Paik M, Bagiella E, et al.: Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 1994, 44:1885–1891.
Loeb C, Gandolfo C, Croce R, Conti M: Dementia associated with lacunar infarction. Stroke 1992, 23:1225–1229.
Mok VC, Wong A, Lam WW, et al.: Cognitive impairment and functional outcome after stroke associated with small vessel disease. J Neurol Neurosurg Psychiatry 2004, 75:560–566.
Vermeer SE, Prins ND, den Heijer T, et al.: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003, 348:1215–1222. This population-based study describes the important role of silent brain infarcts as predictors of cognitive impairment in a general population.
Erkinjuntti T, Haltia M, Palo J, et al.: Accuracy of the clinical diagnosis of vascular dementia: a prospective and postmortem neuropathological study. J Neurol Neurosurg Psychiatry 1988, 51:1037–1044.
Wen HM, Mok VC, Fan YH, et al.: Effect of white matter changes on cognitive impairment in patients with lacunar infarcts. Stroke 2004, 35:1826–1830.
Longstreth WT, Jr., Bernick C, Manolio TA, et al.: Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol 1998, 55:1217–1225.
Vermeer SE, Hollander M, van Dijk EJ, et al.: Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003, 34:1126–1129.
Samuelsson M, Lindell D, Olsson GB: Lacunar infarcts: a 1-year clinical and MRI follow-up study. Cerebrovascular Disease 1994, 3:221–226.
van Zagten M, Boiten J, Kessels F, Lodder J: Significant progression of white matter lesions and small deep (lacunar) infarcts in patients with stroke. Arch Neurol 1996, 53:650–655.
Yamamoto Y, Akiguchi I, Oiwa K, et al.: Adverse effect of nighttime blood pressure on the ocutcome of lacunar infarct patients. Stroke 1998, 29:570–576.
Gotoh F, Tohgi H, Hirai S, et al.: Cilostazol Stroke Prevention Study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis 2000, 9:147–157.
Chinese Acute Stroke Trial. CAST: randomised placebocontrolled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997, 349:1641–1649.
Bousser MG, Eschwege E, Haguenau M, et al.: “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983, 14:5–14.
Gent M, Blakeley JA, Easton D: The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989, 1:1215–1220.
Gorelick PB, Richardson D, Kelly M, et al.: Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 2003, 289:2947–2957.
Diener HC, Bogousslavsky J, Brass LM, et al.: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebocontrolled trial. Lancet 2004, 364:331–337.
Lewington S, Clarke R, Qizilbash N, et al.: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903–1913.
Gueyffier F, Boissel JP, Boutitie F, et al.: Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. Stroke 1997, 28:2557–2562.
Randomised trial of a perindopril-based blood-pressurelowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358:1033–1041.
Chapman N, Huxley R, Anderson C, et al.: Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke 2004, 35:116–121.
Forette F, Seux ML, Staessen JA, et al.: The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002, 162:2046–2052.
Tzourio C, Anderson C, Chapman N, et al.: Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003, 163:1069–1075.
Dufouil C, Mazoyer B, Chalmers J, Tzourio C: Effects of blood pressure lowering on incidence of cerebral white matter lesions in patients with stroke. Neurology 2004, 62:A172.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Benavente, O., White, C.L. & Roldan, A.M. Small vessel strokes. Curr Cardiol Rep 7, 23–28 (2005). https://doi.org/10.1007/s11886-005-0006-6
Issue Date:
DOI: https://doi.org/10.1007/s11886-005-0006-6